Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page version was updated from v3.4.0 to v3.4.1 and a site-wide notice about potential data delays due to a lapse in government funding was added.SummaryDifference0.9%

- Check11 days agoChange DetectedUI and versioning updates include showing the glossary, color-coded highlights, and a new revision label (v3.4.0). These changes do not modify core study data or critical information.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new history revision v3.3.4 was added to the history and the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the Record History, and removed the 'HHS Vulnerability Disclosure' link along with the 'Revision: v3.3.2' entry from the footer.SummaryDifference0.2%

- Check68 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed in the page history, indicating a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.